BlackRock Amends Artivion Stake to 7.8% as of Dec 31, 2023
Ticker: AORT · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 784199
| Field | Detail |
|---|---|
| Company | Artivion, Inc. (AORT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, SC-13G/A
TL;DR
**BlackRock still owns 7.8% of Artivion, showing continued institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, disclosing its ownership in Artivion, Inc. (formerly CryoLife Inc.). As of December 31, 2023, BlackRock reported beneficial ownership of 3,243,620 shares of Artivion's Common Stock, representing 7.8% of the company. This is an update to their previous filing, indicating a slight adjustment in their institutional holding. For investors, this shows that a major institutional investor like BlackRock maintains a significant, albeit slightly adjusted, stake in Artivion, which can be seen as a vote of confidence in the company's long-term prospects.
Why It Matters
This filing confirms BlackRock's continued significant institutional ownership in Artivion, Inc., signaling their ongoing belief in the company's value and potentially influencing other investors.
Risk Assessment
Risk Level: low — This filing is a routine update from a major institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued significant stake as a sign of institutional confidence, but also monitor future filings for any substantial changes in their position, which could signal a shift in their outlook on Artivion.
Key Numbers
- 3,243,620 — Shares Beneficially Owned (Represents BlackRock's total stake in Artivion, Inc. as of December 31, 2023.)
- 7.8% — Percentage of Class (Indicates the proportion of Artivion's common stock owned by BlackRock, a significant institutional holding.)
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Artivion, Inc. (company) — the subject company in which BlackRock holds shares
- CryoLife Inc. (company) — Artivion, Inc.'s former name
- 3,243,620 (dollar_amount) — number of shares beneficially owned by BlackRock
- 7.8% (dollar_amount) — percentage of Artivion's common stock beneficially owned by BlackRock
- December 31, 2023 (date) — the date of the event which required the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will maintain a significant stake in Artivion, Inc. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A is an amendment (Amendment No: 2) filed by BlackRock Inc. to update its beneficial ownership of Common Stock in Artivion, Inc. as of December 31, 2023, under Rule 13d-1(b).
Which company is the subject of BlackRock's ownership disclosure?
The subject company is ARTIVION, INC., which was formerly known as CRYOLIFE INC. until its name change on May 26, 1994.
How many shares of Artivion, Inc. Common Stock does BlackRock Inc. beneficially own according to this filing?
As of December 31, 2023, BlackRock Inc. beneficially owns 3,243,620 shares of Artivion, Inc. Common Stock.
What percentage of Artivion, Inc.'s Common Stock does BlackRock Inc.'s ownership represent?
BlackRock Inc.'s beneficial ownership of 3,243,620 shares represents 7.8% of Artivion, Inc.'s Common Stock.
When was the event date that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding ARTIVION, INC. (AORT).